Skip to main content

Table 1 Baseline characteristics

From: Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial

Characteristic

Patients included in sub-study

Subjects

690

Temperature intervention at 36 C,n = 690

343 (49.7)

Age, years,n = 690

65 [56–73]

Male sex,n = 690

558 (80.9)

Previous medical history

Myocardial infarction,n = 684

134 (19.6)

Ischemic heart disease,n = 683

187 (27.4)

Arrhythmia,n = 684

121 (17.7)

Arterial hypertension,n = 682

277 (40.6)

Diabetes,n = 679

100 (14.7)

Intra-arrest characteristics

Witnessed cardiac arrest,n = 687

614 (89.4)

Cardiac arrest at home,n = 690

364 (52.8)

Bystander cardiopulmonary resuscitation,n = 690

499 (72.3)

No flow time (min),n = 679

1 [0–5]

Low flow time (min),n = 679

22 [14–35]

Dose of adrenaline (mg),n = 680

2 [0–4]

ST-elevation myocardial infarction,n = 676

276 (40.8)

First monitored rhythm,n = 690

Non shockable

128 (18.6)

Shockable

542 (78.6)

Unknown

20 (2.9)

Early hospital characteristics

Moderate shock on admission,n = 686

85 (12.4)

Lactate at admission (mmol/l),n = 619

5.9 [3.2–9.3]

Admission pCO2< 4.5 kPa,n = 645

80 (11.6)

Pupillary or corneal reflexes present on admission,n = 649

7.23 [7.13–7.31]

Admission GCSm > 1 or sedated,n = 679

308 (44.6)

Pupillary or corneal reflexes present on admission,n = 655

527 (76.4)

Extended cardiovascular SOFA score day 1,n = 673

3 [2–4]

Positive cardiovascular deterioration composite at 24 h,n = 670

203 (30.3%)

  1. Baseline characteristics in the TTM biobank population included in the analysis. Continuous data is presented as median value with interquartile range, while categorical data as number of subjects and percentages. n represents the total number of samples available for analysis